Program_Memos / 2002 / AB-02-060

Why This Topic Matters

The memorandum affects how providers and contractors recognize eligible conditions, process claims, and apply billing guidance for a specific covered drug/biologic service. It is important for compliance, claims handling, and understanding when the policy became effective.

Article Sections

1. Coverage

   Summarizes the covered clinical conditions and the general coverage context for the therapy discussed in the memorandum. Also presents the broad eligibility framework referenced by the policy.

2. Intermediary Billing Instructions

   Describes the intermediary billing context, including the claim form reference, applicable billing categories, and payment framework. Also notes the general payment setting information associated with the service.

3. Intermediary - Applicable HCPCS and CPT Codes

   Lists the billing identifiers referenced for intermediary claims and places them in the context of the service described in the memorandum.

4. Intermediary - Applicable Bill Types

   Identifies the bill types referenced for intermediary processing.

5. Intermediary - Applicable Revenue Codes

   Identifies the revenue code referenced for intermediary billing.

6. Intermediary - Payment Requirements

   Summarizes the payment setting and general reimbursement framework referenced for intermediary claims.

7. Carrier Billing Instructions

   Provides the carrier-side billing context and references the relevant billing identifier group for the service.

8. Carrier Payment Requirements

   Describes the carrier payment framework and general cost-sharing context tied to the memorandum.

9. Provider Notification

   Outlines the administrative communication and implementation expectations for notifying providers about the coverage update.